This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pusterla, N.
Right arrow Articles by Dumler, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pusterla, N.
Right arrow Articles by Dumler, J. S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2000, p. 1276-1278, Vol. 38, No. 3
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Experimental Inoculation with Human Granulocytic Ehrlichia Agent Derived from High- and Low-Passage Cell Culture in Horses

Nicola Pusterla,1,* John E. Madigan,1 Kristin M. Asanovich,2 Joon-Seok Chae,1 Elfriede Derock,1 Christian M. Leutenegger,1 Jeannine Berger Pusterla,1 Hans Lutz,3 and J. Stephen Dumler2

Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California 956161; Division of Medical Microbiology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 212872; and Department of Veterinary Internal Medicine, University of Zurich, CH-8057 Zurich, Switzerland3

Received 3 September 1999/Returned for modification 10 December 1999/Accepted 24 December 1999

We report the successful infection throughout intravenous inoculation with low and high passage of in vitro-grown human granulocytic ehrlichiosis (HGE) agent in horses. Differences in disease severity but not in incubation time, hematological changes, PCR detection, ehrlichial load, seroconversion time, and titer range were noted between horses infected with a low and a high passage of in vitro-grown HGE agent.


* Corresponding author. Mailing address: School of Veterinary Medicine, University of California, Davis, CA 95616. Phone: (530) 752-2371. Fax: (530) 752-0414. E-mail: npusterla{at}ucdavis.edu.


Journal of Clinical Microbiology, March 2000, p. 1276-1278, Vol. 38, No. 3
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Scorpio, D. G., Leutenegger, C., Berger, J., Barat, N., Madigan, J. E., Dumler, J. S. (2008). Sequential Analysis of Anaplasma phagocytophilum msp2 Transcription in Murine and Equine Models of Human Granulocytic Anaplasmosis. CVI 15: 418-424 [Abstract] [Full Text]  
  • Choi, K.-S., Dumler, J. S. (2007). Mitogenic Component in Polar Lipid-Enriched Anaplasma phagocytophilum Membranes. CVI 14: 1260-1265 [Abstract] [Full Text]  
  • Miura, K., Rikihisa, Y. (2007). Virulence Potential of Ehrlichia chaffeensis Strains of Distinct Genome Sequences. Infect. Immun. 75: 3604-3613 [Abstract] [Full Text]  
  • Choi, K.-S., Webb, T., Oelke, M., Scorpio, D. G., Dumler, J. S. (2007). Differential Innate Immune Cell Activation and Proinflammatory Response in Anaplasma phagocytophilum Infection. Infect. Immun. 75: 3124-3130 [Abstract] [Full Text]  
  • Dreher, U. M., de la Fuente, J., Hofmann-Lehmann, R., Meli, M. L., Pusterla, N., Kocan, K. M., Woldehiwet, Z., Braun, U., Regula, G., Staerk, K. D. C., Lutz, H. (2005). Serologic Cross-Reactivity between Anaplasma marginale and Anaplasma phagocytophilum. CVI 12: 1177-1183 [Abstract] [Full Text]  
  • Kim, H.-Y., Mott, J., Zhi, N., Tajima, T., Rikihisa, Y. (2002). Cytokine Gene Expression by Peripheral Blood Leukocytes in Horses Experimentally Infected with Anaplasma phagocytophila. CVI 9: 1079-1084 [Abstract] [Full Text]